<DOC>
	<DOCNO>NCT01225640</DOCNO>
	<brief_summary>PNU-100480 develop treatment drug resistant sensitive tuberculosis . This efficacy safety study characterize effect PNU-100480 give 14 day treatment-naive patient drug-sensitive pulmonary tuberculosis .</brief_summary>
	<brief_title>PNU-100480 In Newly Diagnosed , Drug Sensitive Patients With Pulmonary TB ; Early Bactericidal Activity ; Whole Blood Assay</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<criteria>Adult male females 18 65 year ; woman childbearing potential must willing adhere lifestyle requirement regard contraception/pregnancy prevention . Newly diagnose sputum smearpositive pulmonary TB confirm acidfast bacillus ( AFB ) smear chest xray . Patients TB 5 year ago complete treatment , healthy , meet inclusion criterion may include . Body weight 40 90 kg , inclusive ( light clothing , shoe ) . Reasonably normal hemoglobin ( &gt; =8 gm/dL ) , renal function ( serum creatinine &lt; 2 mg/dL ) , hepatic function ( serum AST &lt; 3xULN total bilirubin &lt; 1.3 mg/dL ) , random glucose &lt; 150 mg/dL . HIV infection helper/inducer Tlymphocytes ( CD4 cell ) count &lt; =350x106/L . Presence significant hemoptysis . Subjects cough frank blood ( blood streak sputum ) eligible . Pregnant nursing female ; female childbearing potential unwilling unable adhere contraception guideline . Significant respiratory impairment ( respiratory rate &gt; 35/minute ) . Clinical suspicion disseminate TB tuberculosis meningitis . Subjects diabetes mellitus insulin and/or poorly control disease . Subjects confirm suspected multidrug resistant TB .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>EBA</keyword>
	<keyword>WBA</keyword>
</DOC>